“Vortioxetine Improves Gastrointestinal Motility and Reduces Intestinal Inflammation in a Cuprizone-Induced Multiple Sclerosis Model in Mice”. 2026. Annals of Medical Research 33 (5): 192-98. http://www.annalsmedres.org/index.php/aomr/article/view/4909.